DL
Biomed Pipeline
| Drug | Indication | Phase |
|---|---|---|
| NA-704 | Amyotrophic Lateral Sclerosis (ALS) | Phase 2B |
| NA-731 | Traumatic Brain Injury | Phase 2A |
| NA-831 | Mild and Moderate Alzheimer's Disease | Phase 2B/3 |
| NA-841 | Huntington's Disease | Phase 2A |
| NA-901 | Major Depressive Disorder | Phase 2B/3 |
| NA-911 | Stroke | Phase 2A |
| NA-921 | Rett Syndrome and Fragile X | Phase 3 |
| NA-931 | Diabetes Obesity | Phase 2B/3 |